C07H 19/22
Pteridine radicals
C07H19/22 (Pteridine radicals) appears on 40 US grants and 60 published applications in this corpus.
Search patents in C07H- Granted patents
- 40
- Published applications
- 60
- Assignees
- 42
- Inventors
- 120
- Latest grant
- 13 Aug 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 1 | 6 |
| 2005 | 1 | 6 |
| 2006 | 1 | 13 |
| 2007 | 4 | 10 |
| 2008 | 8 | 2 |
| 2009 | 8 | 7 |
| 2010 | 1 | 3 |
| 2011 | 1 | 0 |
| 2012 | 4 | 1 |
| 2013 | 1 | 3 |
| 2014 | 2 | 3 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
| 2018 | 0 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Analogs of adenosine monophosphate (AMP) as inhibitors of ubiquitin-like modifier-activating enzyme ATG713 Aug 2019US 10,376,515 B2Northwestern University
- Selective inhibitors of translesion DNA replication17 Mar 2015US 8,981,078 B2Case Western Reserve University
- Anti-microbial agents and uses thereof3 Feb 2015US 8,946,188 B2Cornell Research Foundation, Inc.
- Bicyclic nucleosides and nucleotides as therapeutic agents12 Aug 2014US 8,802,840 B2Biota Scientific Management Pty Ltd.
- Modified 2′ and 3′ nucleoside prodrugs for treating flaviviridae infections28 Jan 2014US 8,637,475 B1Centre National De La Recherche Scientifique
- Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections28 Jan 2021US 2021/0024565 A1Centre National De La Recherche Scientifique
- Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections23 Aug 2018US 2018/0237467 A1Centre National De La Recherche Scientifique
- Analogs of adenosine monophosphate (amp) as inhibitors of ubiquitin-like modifier-activating enzyme atg72 Nov 2017US 2017/0312284 A1Northwestern University
- Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections30 Mar 2017US 2017/0088577 A1Centre National De La Recherche Scientifique
- Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infections15 Jan 2015US 2015/0017124 A1Centre National De La Recherche Scientifique
Most cited
By later US patents
- Pteridine nucleotide analogs as fluorescent DNA probes565US 5,525,711 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1996
- Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections149US 7,608,600 B2Centre National De La Recherche Scientifique · 2009
- Modified 2′ and 3′-nucleoside prodrugs for treating Flavivridae infections100US 7,365,057 B2Centre National De La Recherche Scientifique · 2008
- Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections98US 7,635,689 B2Centre National De La Recherche Scientifique · 2009
- Adenosine analogues and their use as pharmaceutical agents81US 7,265,111 B2Sanofi-Aventis Deutschland GmbH · 2007